News

27-08-2019 LEO Pharma files IND application to FDA for a clinical study of JW1601/LP0190 in the US
13-08-2019 LEO Pharma A/S acquires rights to develop and market brodalumab for moderate-to-severe psoriasis outside of Europe
01-07-2019 LEO Pharma completes the acquisition of Bayer’s prescription dermatology business

Read our Annual Report 2018

Global presence

See LEO Pharma global presence See LEO Pharma global presence

By listening to people with skin conditions, LEO Pharma develops complete care solutions that meet patient needs
 

 

Working at LEO Pharma

We understand that people power our success. Our global team – consisting of around 5,500 people in 61 countries worldwide – is LEO Pharma’s greatest asset. This is why we continually seek to attract passionate, dedicated and solution-orientated people – and ensure that our people develop their talent.

Partner with LEO Pharma

We use cookies on this website

The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information.

By continuing to browse our website, you are agreeing to our use of cookies

If you want to know more about our cookie policy and how to avoid and delete cookies click here.